Taiwan's Pharmaceutical Market to Reach $8.4 Billion by 2020

Pharmaceutical Processing reports that, according to a new report from GlobalData, Taiwan’s pharmaceutical market will grow from $5.4 billion in 2013 to $8.4 billion by 2020. This expansion is expected to occur despite the ongoing tensions with China which could potentially hinder Taiwan’s economic growth.
According to the article:
The company’s latest report states that diplomatic isolation, high out-of-pocket expenditure and the inefficient distribution of healthcare facilities are the foremost challenges to Taiwan’s pharmaceutical sector.
[…] Despite these reservations, Taiwan’s pharmaceutical outlook remains positive, with opportunities presented by a free trade agreement with the US, low-taxation investment environment, harmonized clinical trial process, an efficient patent system, and strong incentives for Research and Development (R&D).
Click here to read the full article on Pharmaceutical Processing.